Targeting glucocorticoid receptor to enhance immunotherapy response in triple negative breast cancer
Abstract Background Immune checkpoint blockade (ICB) therapies for triple negative breast cancer (TNBC) have yielded limited clinical benefits, which may be attributed to the immunosuppressive tumor immune microenvironment (TIME). Glucocorticoid receptor (GR) has long been thought to suppress immuni...
Guardat en:
| Autors principals: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BMC
2026-01-01
|
| Col·lecció: | Breast Cancer Research |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s13058-026-02230-x |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|